Zanamivir 5 mg/blister Suppliers & Bulk Manufacturers
Available Forms: Inhalation powder
Available Strengths: 5 mg/blister
Reference Brands: Relenza(EU & US)
Category: Anti Viral
Zanamivir (Relenza) is an inhaled antiviral used to treat and prevent Influenza A and B. It’s effective when used early and is approved for adults and children via a Diskhaler device.
Product Description:
Zanamivir, marketed under the brand name Relenza, is an FDA- and EMA-approved antiviral drug used for the treatment and prevention of Influenza A and B. As a neuraminidase inhibitor, Zanamivir prevents the release of new virus particles from infected cells, reducing flu severity and duration when started within 48 hours of symptoms. It is administered via oral inhalation using a Diskhaler, with each dose delivering 10 mg (two 5 mg blisters). Zanamivir is approved for use in adults and children (≥7 years for treatment, ≥5 for prevention). Relenza offers a localized delivery option with minimal systemic side effects.
Zanamivir — third party manufacturing & bulk supply
Zanamivir 5 mg/blister is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Zanamivir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Zanamivir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Zanamivir is used to treat and prevent influenza A and B infections. It works by inhibiting the viral neuraminidase enzyme, which stops the release of new virus particles from infected cells, helping reduce the severity and duration of flu symptoms when taken early.
Zanamivir is a synthetic neuraminidase inhibitor derived from sialic acid analogues. Its structure is designed to bind tightly to the active site of the neuraminidase enzyme, blocking viral replication.
The most well-known trade name for Zanamivir is Relenza.
Relenza is manufactured by GlaxoSmithKline (GSK).
The generic name of the product is zanamivir.
The commonly known brand name is Relenza.
Zanamivir (Relenza) is manufactured by GlaxoSmithKline in its approved global production facilities, with distribution depending on regional regulatory approvals.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
